May 10, 2024 · ... medications, and medicines that treat autoimmune diseases, metabolic diseases and cardiovascular diseases. Hengrui Pharma has been on the ...
Jiangsu Hengrui
Pharmaceutical company
Jiangsu Hengrui Pharmaceuticals Company Ltd., also known as Jiangsu Hengrui, is a Chinese pharmaceutical company that manufactures and distributes various types of drug packaging materials, cancer-treating antineoplastics, cardiovascular... Wikipedia
People also ask
Who is the owner of Jiangsu Hengrui medicine?
Hengrui is a leading global pharmaceutical company headquartered in China with a focus on research, development, manufacturing, and commercialization of ...
Jiangsu Hengrui Medicine Co., Ltd., a pharmaceutical company, develops, manufactures, and commercializes drugs worldwide. The company is developing ...
An anti-PD-1 immune checkpoint inhibitor camrelizumab for hepatocellular carcinoma; · A nonsteroidal antiandrogen rezvilutamide for prostate cancer; · A PARP ...
Benefit the patients with high-quality medication as we determined to innovate. Innovation-driven. Build a leading global biopharmaceutical group
Jiangsu Hengrui Medicine Co., Ltd. engages in the research, development, manufacture, and sale of drugs. It specializes in antineoplastic agents, surgical.
Hengrui Therapeutics, based in Princeton NJ, was founded in 2016 as a $100 million joint venture between Hengrui Medicine and a leading global investment firm, ...
2 days ago · As for camrelizumab, Hengrui last year out-licensed the drug's rights in unresectable liver cancer outside China and Korea to Elevar. HLB ...